RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Calhoun to Kidney

This is a "connection" page, showing publications David Calhoun has written about Kidney.
Connection Strength

0.802
  1. Grassi G, Calhoun DA. Sympathetic-vascular interactions: further evidence in kidney transplantation. J Hypertens. 2002 Mar; 20(3):379-81.
    View in: PubMed
    Score: 0.178
  2. Eirin A, Saad A, Woollard JR, Juncos LA, Calhoun DA, Tang H, Lerman A, Textor SC, Lerman LO. Glomerular Hyperfiltration in Obese African American Hypertensive Patients Is Associated With Elevated Urinary Mitochondrial-DNA Copy Number. Am J Hypertens. 2017 Nov 01; 30(11):1112-1119.
    View in: PubMed
    Score: 0.132
  3. Dudenbostel T, Calhoun DA. Effects of Spironolactone and Renal Denervation Treatment on Blood Pressure and Its Variability-Different Aspects of Hypertension Treatment. Am J Hypertens. 2017 01; 30(1):12-15.
    View in: PubMed
    Score: 0.123
  4. Calhoun DA. Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension. J Hypertens. 2016 09; 34(9):1701-3.
    View in: PubMed
    Score: 0.122
  5. Calhoun DA. Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension. Circulation. 2016 09 20; 134(12):858-60.
    View in: PubMed
    Score: 0.121
  6. Pisoni R, Acelajado MC, Cartmill FR, Dudenbostel T, Dell'Italia LJ, Cofield SS, Oparil S, Calhoun DA. Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease. J Hum Hypertens. 2012 Aug; 26(8):502-6.
    View in: PubMed
    Score: 0.085
  7. Oparil S, Calhoun DA. The calcium antagonists in the 1990s. An overview. Am J Hypertens. 1991 Jul; 4(7 Pt 2):396S-405S.
    View in: PubMed
    Score: 0.021
  8. Sakawi Y, Tarpey M, Chen YF, Calhoun DA, Connor MG, Chestnut DH, Parks DA. Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia. Anesthesiology. 2000 Dec; 93(6):1446-55.
    View in: PubMed
    Score: 0.010
  9. Edstrom CS, Calhoun DA, Christensen RD. Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev. 2000 Aug; 59(2):77-84.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support